Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Eva M.
Eva M. Sackal, Altamont, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100275807 | PHOTOLUMINESCENT NANOCRYSTAL BASED TAGGANTS - A taggant for marking a target through the use of a carrier or a projectile loaded on a firing device and methods for fabricating the same are disclosed. The taggant including photoluminescent semiconductor nanocrystal(s) materials incorporated in a carrier or projectile. The photoluminescent semiconductor nanocrystal(s) materials may be encapsulated in a medium for facilitating marking of the target. | 11-04-2010 |
Eva M. Sevick-Muraca, Montgomery, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20110071403 | FUNCTIONAL NEAR-INFRARED FLUORESCENCE LYMPHATIC MAPPING FOR DIAGNOSING, ACCESSING, MONITORING AND DIRECTING THERAPY OF LYMPHATIC DISORDERS - Methods and imaging agents are used to functionally image lymph structures and to identify, diagnose, assess, monitor and direct therapies for lymphatic disorders. Embodiments of the methods utilize highly sensitive optical imaging and fluorescent spectroscopy techniques capable of rapid temporal resolution to non-invasively track or monitor packets of imaging agents flowing in one or more lymphatic structures in human patients to provide quantitative information regarding lymph propulsion and functionality of the lymphatic structures. An imaging agent comprises a fluorophore labeled peptide capable of binding integrin α | 03-24-2011 |
Eva M. Sevick-Muraca, College Station, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20100305453 | IMAGING OF LIGHT SCATTERING TISSUES WITH FLUORESCENT CONTRAST AGENTS - A system and method for non-invasive biomedical optical imaging and spectroscopy with low-level light is described. The technique includes a modulated light source coupled to tissue to introduce excitation light. Fluorescent light emitted in response to the excitation light is detected with a sensor. The AC intensity and phase of the excitation and detected fluorescent light is provided to a processor operatively coupled to the sensor. A processor employs the measured emission kinetics of excitation and fluorescent light to “map” the spatial variation of one or more fluorescence characteristics of the tissue and generate a corresponding image of the tissue via an output device. The fluorescence characteristic may be provided by exogenous contrast agents, endogenous fluorophores, or both. A technique to select or design an exogenous fluorescent contrast agent to improve image contrast is also disclosed. | 12-02-2010 |
